CeRNA-related networks in the regulatory metabolic pathway in mice with diabetic nephropathy were analyzed by RNA-seq analysis based on Empagliflozin intervention

In this study, we conducted bioinformatics analysis of the gene chip data of Empagliflozin for diabetic kidney disease (DN). The differentially expressed genes of DN of diabetic kidney disease mice and NC of control group as well as DN of diabetic nephropathy group and DNE of diabetic nephropathy group and engliazine treatment were screened to explore the related pathogenesis and predict the potential mechanism of Empagliflozin treatment of DN.